The generic drug industry in the U.S. has saved people billions of dollars, but shortages are now the norm and competition is ...

Insulin, used by millions of Americans, has taken center stage in the high-stakes battle over health care costs. Though ...

The development of biological drugs such as gene and cell therapies and vaccines is boosting the production of injectable drug products in the global healthcare market. Chronic illnesses, an ageing ...

The complaint targets the group purchasing organizations affiliated with the "big three" pharmacy benefit managers: CVS ...

Beyond MariTide, Amgen has a rich pipeline with more than 30 phase 3 programs. Some are for existing medicines seeking label expansions, such as Lumakras and Amjevita, a rheumatoid arthritis medicine.

Wave goodbye to the Part D "donut hole" and hello to a $2,000 cap on the amount you'll pay for medications. But other changes ...

Medicare Part D provides prescription drug coverage for those enrolled in Medicare and can significantly help in the ...

The owner of one of the three largest pharmacy middlemen in the United States on Tuesday filed suit to quash an attempt by ...

Merck’s MRK stock has declined around 10.3% in the past three months, losing almost $32 billion of its market value. Merck ...

The Indian market has shown robust performance, rising 1.2% over the last week and climbing 41% in the past year, with ...

A new AARP poll reveals that the majority of women voters aged 50 and over are increasingly worried about the country's economic challenges, with 69% reporting worsening economic security for seniors.

The documents were needed to verify testing and manufacturing practices at Granules, a company in Telangana, India, that supplies generic medications to the U.S., officials say. More pharmaceutical ...